Schedule 13G/A: First Light and CEO Arens Report 16.36% of PHLT
Rhea-AI Filing Summary
Performant Healthcare, Inc. is reported to have two related reporting persons disclosing substantial common stock holdings. First Light Asset Management, LLC discloses shared beneficial ownership of 12,183,915 shares, representing 15.42% of the class. Mathew P. Arens discloses aggregate beneficial ownership of 12,923,915 shares, representing 16.36% of the class, comprised of shares held by the Manager plus 210,000 shares and a 530,000-share joint account directly associated with Mr. Arens. The filing states these holdings are in the ordinary course of business and not intended to change or influence control of the issuer.
Positive
- Material stake disclosed: First Light reports 12,183,915 shares (15.42%), and Mathew P. Arens reports 12,923,915 shares (16.36%)—clear transparency on ownership
- Filing classifies holdings as passive: The reporting persons state shares are held in the ordinary course of business and not to influence control
Negative
- None.
Insights
TL;DR: Two related reporting persons hold a material minority stake (15–16%), disclosed as passive and ordinary-course holdings.
This Schedule 13G/A shows an institutional investment adviser (First Light) and its managing member (Mathew Arens) reporting combined ownership exceeding 15% of Performant Healthcare common stock. The Manager reports shared voting and dispositive power over 12,183,915 shares while Mr. Arens reports both sole and shared powers totaling 12,923,915 shares. The filing explicitly states holdings are ordinary-course and not for control; that classification generally implies a passive investor posture under the Exchange Act.
TL;DR: Disclosure signals a significant shareholder relationship without an asserted intent to control the company.
The joint filing and attached certification assert passive intent, which affects disclosure obligations and market interpretation. The reported percentages (15.42% and 16.36%) cross common materiality thresholds, triggering investor attention and potential engagement by the reporting persons, but the filing's explicit statement that the holdings are not for the purpose of influencing control is consistent with a Schedule 13G treatment rather than a Schedule 13D. From a governance perspective, such a position can nevertheless create influence through informal engagement, though no such actions are described in this filing.